Neptune Wellness Solutions Inc Quick Ratio (NEPT) starting from the third quarter 2023 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Neptune Wellness Solutions Inc   (NASDAQ: NEPT)

Neptune Wellness Solutions Inc 's Quick Ratio

NEPT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 0.03 below Neptune Wellness Solutions Inc average.

Within Major Pharmaceutical Preparations industry 41 other companies have achieved higher Quick Ratio than Neptune Wellness Solutions Inc in third quarter 2023. While Quick Ratio total ranking has improved so far during the Q3 2023 to 809, from total ranking in the second quarter 2023 at 3972.

Explain Quick Ratio?
How much Cash & cash equivalents NEPT´s has?
What are NEPT´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NEPT Quick Ratio (Dec 31 2023)
Q3		 (Sep 30 2023)
Q2		 (Jun 30 2023)
Q1		 (Mar 31 2023)
Q4		 (Dec 31 2022)
Q3
Y / Y Current Liabilities Change 106.72 % 48.5 % 81.88 % 78.86 % 58.67 %
Y / Y Cash & cash equivalent Change -50.63 % 149.8 % -71.25 % -78.73 % -94.68 %
Quick Ratio MRQ 0.03 0.1 0.03 0.02 0.11
NEPT's Total Ranking # 809 # 3972 # 4414 # 4286 # 3862
Seq. Current Liabilities Change 30.53 % -18.15 % -39.48 % 219.73 % -6.23 %
Seq. Cash & cash equivalent Change -64.55 % 152.41 % -6.29 % -41.12 % 79.38 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 42
Healthcare Sector # 100
Overall Market # 809


Quick Ratio Statistics
High Average Low
0.96 0.42 0.02
(Mar 31 2020)   (Dec 31 2023)




Financial Statements
Neptune Wellness Solutions Inc 's Current Liabilities $ 46 Millions Visit NEPT's Balance sheet
Neptune Wellness Solutions Inc 's Cash & cash equivalent $ 1 Millions Visit NEPT's Balance sheet
Source of NEPT's Sales Visit NEPT's Sales by Geography


Cumulative Neptune Wellness Solutions Inc 's Quick Ratio

NEPT's Quick Ratio for the trailling 12 Months

NEPT Quick Ratio

 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 78.59 % 69.65 % 76.46 % 75.12 % 102.93 %
Y / Y Cash & cash equivalent TTM Growth -51.53 % -85.31 % -90.53 % -87.13 % -81.55 %
Quick Ratio TTM 0.04 0.05 0.04 0.07 0.15
Total Ranking TTM # 4718 # 3073 # 4061 # 4133 # 3412
Seq. Current Liabilities TTM Growth 13.83 % 7.19 % 13.77 % 28.66 % 8.13 %
Seq. Cash & cash equivalent TTM Growth -14.33 % 30.95 % -33.63 % -34.89 % -74.03 %

Quick ratio ranking by company, industry and sector >> Back to NEPT Financial Strength Comparisons >> Go to Compare NEPT Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q3 2023 to $45.61 millions, cumulative Quick Ratio decreased to 0.04 below the Neptune Wellness Solutions Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 573 other companies have achieved higher Quick Ratio than Neptune Wellness Solutions Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3073 to 4718.

Explain Quick Ratio?
How much Cash & cash equivalents NEPT´s has?
What are NEPT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 574
Healthcare Sector # 1163
Within the Market # 4718


trailing twelve months Quick Ratio Statistics
High Average Low
1.27 0.64 0.05
(Dec 31 2021)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2023 MRQ Cash & cash equivalentDec 31 2023 MRQ Current Liabilities
Biofrontera Inc   0.07 $ 1.343  Millions$ 18.088  Millions
REST EZ Inc.  0.06 $ 0.003  Millions$ 0.042  Millions
Cnbx Pharmaceuticals Inc   0.05 $ 0.082  Millions$ 1.560  Millions
Orgenesis Inc   0.05 $ 0.837  Millions$ 16.407  Millions
Emmaus Life Sciences Inc   0.04 $ 2.547  Millions$ 60.733  Millions
Semnur Pharmaceuticals Inc   0.04 $ 0.205  Millions$ 5.098  Millions
Kairos Pharma Ltd   0.04 $ 0.093  Millions$ 2.401  Millions
Procaps Group S a   0.04 $ 17.514  Millions$ 494.714  Millions
Rain Enhancement Technologies Holdco Inc   0.03 $ 0.037  Millions$ 1.128  Millions
One World Products Inc   0.03 $ 0.086  Millions$ 2.978  Millions
Neptune Wellness Solutions Inc   0.03 $ 1.251  Millions$ 45.608  Millions
Earth Science Tech Inc   0.03 $ 0.036  Millions$ 1.307  Millions
Regen Biopharma Inc   0.02 $ 0.121  Millions$ 5.308  Millions
Oncotelic Therapeutics Inc   0.02 $ 0.170  Millions$ 7.595  Millions
Cytodyn inc   0.02 $ 2.541  Millions$ 119.796  Millions
Lunai Bioworks Inc   0.02 $ 0.244  Millions$ 13.758  Millions
Citius Oncology Inc  0.02 $ 0.033  Millions$ 2.046  Millions
Scienture Holdings Inc   0.01 $ 0.152  Millions$ 10.937  Millions
60 Degrees Pharmaceuticals Inc   0.01 $ 0.265  Millions$ 19.434  Millions
Hst Global Inc   0.01 $ 0.002  Millions$ 0.114  Millions
Provectus Biopharmaceuticals Inc   0.01 $ 0.077  Millions$ 7.420  Millions
Accustem Sciences Inc   0.01 $ 0.021  Millions$ 2.246  Millions
Actavia Life Sciences Inc   0.01 $ 0.019  Millions$ 2.130  Millions
Nexien Biopharma Inc   0.01 $ 0.003  Millions$ 0.317  Millions
Bioxytran Inc   0.01 $ 0.026  Millions$ 3.244  Millions
Os Therapies Incorporated  0.01 $ 0.039  Millions$ 4.933  Millions
Biostax Corp  0.01 $ 0.035  Millions$ 4.563  Millions

Date modified: 2026-08-31T07:36:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.